King Hussein Cancer Center
Amman, Jordan
4 recruiting
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
Metastatic Breast Cancer
Hoffmann-La Roche230 enrolled192 locationsNCT05894239
Recruiting
Phase 2
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
CNS TumorHigh Grade Glioma
St. Jude Children's Research Hospital52 enrolled4 locationsNCT06528691
Recruiting
Not Applicable
MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia
Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia RefractoryAcute Lymphoblastic Leukemia With Failed Remission+2 more
King Hussein Cancer Center12 enrolled1 locationNCT07371403
Recruiting
Phase 2
Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL
Non-Hodgkin Lymphoma Refractory/ Relapsed
King Hussein Cancer Center26 enrolled1 locationNCT07271121
Recruiting
ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
Cancer of ProstateCancer Head NeckCancer Cervix
University College, London990 enrolled6 locationsNCT05653063
Recruiting
Not Applicable
SBRT for Breast Cancer Oligometastases
Breast Neoplasm Malignant Female
King Hussein Cancer Center50 enrolled1 locationNCT04424732